U.S. company assumes control of Outlook salesPicker Nordstar, the novel manufacturing/marketing joint venturebetween Picker International and Instrumentarium Imaging in Helsinki,Finland, took an unexpected turn in late March when
Picker Nordstar, the novel manufacturing/marketing joint venturebetween Picker International and Instrumentarium Imaging in Helsinki,Finland, took an unexpected turn in late March when Cleveland-basedPicker bought its partner's shares in the venture.
Operations associated with the 0.23-tesla Outlook, an open-architectureMRI scanner designed and manufactured by Nordstar and marketedby Picker, have been integrated into Picker's MRI division. PickerNordstar will remain headquartered in Helsinki.
Outlook was introduced at the 1994 Radiological Society ofNorth America meeting (SCAN 11/23/94). The scanner is an iron-coreresistive magnet system that employs a technology called electronspin resonance (ESR) to achieve a more stable magnetic field.
Picker and Instrumentarium formed the Nordstar joint venturein 1993 (SCAN 2/10/93). The deal marked Picker's return to thelow-field segment by allowing it to take over sales of Instrumentarium'sMerit 0.1-tesla scanner, as well as MRI R&D technology underdevelopment at Instrumentarium, such as Overhauser MRI. Meritis still being sold, primarily in international markets.
Picker's buyout of Instrumentarium's share of Nordstar is acontinuation of Picker's strategy in the MRI market and will boostthe vendor's prospects in Europe, according to Linda Eastwood,MR group manager.
"It gives us the benefit of working together far moreclosely and it gives us a new base in Europe," she said.
Picker gained complete control over Outlook and the Helsinki-basedengineering group responsible for its development. Robert Gyllingwill continue to manage Nordstar under the new Picker ownership,Eastwood said.
The deal does not affect a separate marketing and manufacturingagreement that assigned Picker the rights to sell Neuromag-122,a magnetoencephalography system. Nordstar will continue to providesome manufacturing and Picker will continue to sell products forthe company, Eastwood said.
Outlook scanner owners will not notice any differences becauseof the ownership change, according to Eastwood.
"The customers were already buying from Picker. It isa Picker product. It is just more fully a Picker product now,"she said.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
2 Commerce Drive
Cranbury, NJ 08512